Cargando…

Comments to Prediction of Advanced Fibrosis in Nonalcoholic Fatty Liver Disease: An Enhanced Model of BARD Score

Detalles Bibliográficos
Autor principal:	Guan, Yong-Song
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The Korean Society of Gastroenterology; the Korean Society of Gastrointestinal Endoscopy; the Korean Association for the Study of the Liver; the Korean Society of Neurogastroenterology and Motility; Korean Association for the Study of Intestinal Diseases; Korean College of Helicobacter and Upper Gastrointestinal Research; Korean Pancreatobiliary Association; Korean Society of Gastrointestinal Cancer 2014
Materias:	Letter to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3964276/ https://www.ncbi.nlm.nih.gov/pubmed/24672667 http://dx.doi.org/10.5009/gnl.2014.8.2.228

Ejemplares similares

Prediction of Advanced Fibrosis in Nonalcoholic Fatty Liver Disease: An Enhanced Model of BARD Score
por: Lee, Tae Hoon, et al.
Publicado: (2013)

The BARD score and the NAFLD fibrosis score in the assessment of advanced liver fibrosis in nonalcoholic fatty liver disease
por: Cichoż-Lach, Halina, et al.
Publicado: (2012)

Validation of the BARD scoring system in Polish patients with nonalcoholic fatty liver disease (NAFLD)
por: Raszeja-Wyszomirska, Joanna, et al.
Publicado: (2010)

Comment on “Gut Microbiota as a Driver of Inflammation in Nonalcoholic Fatty Liver Disease”
por: Li, Xia, et al.
Publicado: (2018)

Comment on “Advanced Hepatic Fibrosis in Fatty Liver Disease Linked to Hyperplastic Colonic Polyp”
por: Ribaldone, Davide Giuseppe, et al.
Publicado: (2017)

Response to: Comment on “Gut Microbiota as a Driver of Inflammation in Nonalcoholic Fatty Liver Disease”
por: Bibbò, Stefano, et al.
Publicado: (2018)

Comments on validation of conventional non-invasive fibrosis scoring systems in patients with metabolic associated fatty liver disease
por: Hong, Jian-Guo, et al.
Publicado: (2022)

The Development of the Pediatric NAFLD Fibrosis Score (PNFS) to Predict the Presence of Advanced Fibrosis in Children with Nonalcoholic Fatty Liver Disease
por: Alkhouri, Naim, et al.
Publicado: (2014)

Importance of Variables in Nonalcoholic Fatty Liver Disease Patients
por: Garg, Vivek Kumar, et al.
Publicado: (2018)

Diagnostic Performance of the Fibrosis-4 Index and Nonalcoholic Fatty Liver Disease Fibrosis Score in Lean Adults With Nonalcoholic Fatty Liver Disease
por: Park, Huiyul, et al.
Publicado: (2023)

Letter regarding “Risk factors in nonalcoholic fatty liver disease”
por: Pratap, Abhijit, et al.
Publicado: (2023)

Risk Stratification of Advanced Fibrosis in HIV Patients With Hepatic Steatosis Using the NAFLD Fibrosis and BARD Scores
por: YENDEWA, George A., et al.
Publicado: (2023)

Performance of the Enhanced Liver Fibrosis Test to Estimate Advanced Fibrosis Among Patients With Nonalcoholic Fatty Liver Disease
por: Younossi, Zobair M., et al.
Publicado: (2021)

Nonalcoholic Fatty Liver Disease: Role of Medical Colleges in its Prevention and Control
por: Nath, Bhola, et al.
Publicado: (2022)

Letter regarding “Auranofin attenuates hepatic steatosis and fibrosis in nonalcoholic fatty liver disease via NRF2 and NF-κB signaling pathways”
por: Liu, Yuanbin, et al.
Publicado: (2023)

Comments on “The Effects of Aerobic and Resistance Exercise Training on Liver Enzymes and Hepatic Fat in Iranian Men With Nonalcoholic Fatty Liver Disease”
por: Cheraghpour, Makan, et al.
Publicado: (2016)

Validation model of fibrosis-8 index score to predict significant fibrosis among patients with nonalcoholic fatty liver disease
por: Prasoppokakorn, Thaninee, et al.
Publicado: (2022)

Clinical predictive score for detecting nonalcoholic fatty liver disease with significant fibrosis in patients with metabolic syndrome
por: Kositamongkol, Chayanis, et al.
Publicado: (2021)

Correspondence on Letter regarding “Auranofin attenuates hepatic steatosis and fibrosis in nonalcoholic fatty liver disease via NRF2 and NF-κB signaling pathways”
por: Lee, Seung Min, et al.
Publicado: (2023)

Comments on Relationship between the High Fatty Liver Index and Risk of Fracture
por: Lai, Shih-Wei, et al.
Publicado: (2023)

Combination of Fibrosis-4, liver-stiffness measurement, and Fibroscan-AST score to predict liver-related outcomes in nonalcoholic fatty liver disease
por: Wong, Yu Jun, et al.
Publicado: (2023)

Relationship between nonalcoholic fatty liver disease and chronic kidney disease could start in childhood
por: Di Sessa, Anna, et al.
Publicado: (2021)

Use of a Diabetes Self-Assessment Score to Predict Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis
por: Kim, Gyuri, et al.
Publicado: (2015)

Biochemical Scoring System for diagnosing Nonalcoholic Steatohepatitis
por: Noor-E-Alam, Mohammad, et al.
Publicado: (2016)

Visceral Obesity Predicts Significant Fibrosis in Patients With Nonalcoholic Fatty Liver Disease
por: Yu, Su Jong, et al.
Publicado: (2015)

Comments on Relationship between the High Fatty Liver Index and Risk of Fracture: Reply
por: Kim, Min-Ji, et al.
Publicado: (2023)

The Importance of Visceral Adipose Tissue Detected by Imaging Methods to Assess Nonalcoholic Fatty Liver Disease Properly
por: Ozcelik, Fatih, et al.
Publicado: (2021)

No Association Between Nonalcoholic Fatty Liver Disease and Severe COVID-19? Something We Might Ignore
por: Gao, Hui, et al.
Publicado: (2022)

Serum folate associated with nonalcoholic fatty liver disease and advanced hepatic fibrosis
por: Chen, Hao-Kai, et al.
Publicado: (2023)

Circulating Citrate Is Associated with Liver Fibrosis in Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis
por: Amjad, Waseem, et al.
Publicado: (2023)

Serum markers for predicting advanced fibrosis in patients with chronic hepatitis B and nonalcoholic fatty liver disease
por: Wang, Qi, et al.
Publicado: (2021)

Body Composition and Genetic Lipodystrophy Risk Score Associate With Nonalcoholic Fatty Liver Disease and Liver Fibrosis
por: Chen, Vincent L., et al.
Publicado: (2019)

Comments to Metallothionein as an Anti-Inflammatory Mediator
por: Guan, Yong-Song
Publicado: (2009)

Prediction of Cardiovascular Risk Using Nonalcoholic Fatty Liver Disease Scoring Systems
por: Kweon, Ye-Na, et al.
Publicado: (2021)

Comments on Prevalence of Non-alcoholic Fatty Liver Disease and Its Related Factors in Iran
por: Karimi-Sari, H., et al.
Publicado: (2017)

Incidence of hepatocellular carcinoma in nonalcoholic fatty liver disease without cirrhosis or advanced liver fibrosis
por: Behari, Jaideep, et al.
Publicado: (2023)

A novel model for detecting advanced fibrosis in patients with nonalcoholic fatty liver disease
por: Yang, Xinyu, et al.
Publicado: (2022)

Risk of advanced fibrosis in first-degree relatives of patients with nonalcoholic fatty liver disease
por: Tamaki, Nobuharu, et al.
Publicado: (2022)

Limited expression of toll-like receptor 9 on T cells and its functional consequences in patients with nonalcoholic fatty liver disease
por: Yu, Jung Hwan
Publicado: (2020)

Advanced Liver Fibrosis Is Associated with Chronic Kidney Disease in Patients with Type 2 Diabetes Mellitus and Nonalcoholic Fatty Liver Disease (Diabetes Metab J 2022;46:630-9)
por: Huh, Ji Hye
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_248u5e22ogcrhfi9dgt7610v3n